Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,939.00p
   
  • Change Today:
    -25.00p
  • 52 Week High: 2,340.00p
  • 52 Week Low: 1,772.00p
  • Currency: UK Pounds
  • Shares Issued: 221.89m
  • Volume: 1,793,541
  • Market Cap: £4,302.38m
  • RiskGrade: 125
  • Beta: 0.02

HIK Overview

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma’s operations are in the United States, the Middle East and North Africa Region and Europe.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 3.1% 0.0%
Div Cover 2.8 2.8
Op Mrgn 19.6% 22.0%
ROCE 24.3%  
Latest F'cast
P/E 11.5 11.6
PEG 25.6 3.9
Pr/Revenue 1.8 1.4
Pr/Book 2.5  
Latest F'cast
Revenue 8.8% -20.3%
PBT 61.9% 20.7%
EPS 0.4% 3.0%
DPS 11.1% -41.6%

HIK Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 2,341.00 558.00 172.90¢ 19.3 1.3 +15% 50.00¢ 1.5%
31-Dec-21 2,553.00 544.00 194.80¢ 15.1 1.2 +13% 54.00¢ 1.8%
31-Dec-22 2,517.00 233.00 181.00¢ 11.4 n/a -7% 56.00¢ 2.7%
31-Dec-23 2,875.00 281.00 223.00¢ 10.7 0.5 +23% 72.00¢ 3.0%
31-Dec-24 3,127.00 455.00 224.00¢ 11.8 n/a 0% 80.00¢ 3.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

HIK Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 3,311.10 729.24 171.62p 11.3 3.8 +3% 62.06p 0.0%
31-Dec-26 3,474.19 788.22 189.05p 10.3 1.0 +10% 67.10p 0.0%
31-Dec-27 3,685.62 851.92 208.59p 9.3 0.9 +10% 73.40p 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

HIK Company Announcements

Notice of Results 09-Jul-2025 09:00 RNS
Publication of Offering Circular 07-Jul-2025 09:16 RNS
Director/PDMR Shareholding 09-Jun-2025 15:33 RNS

HIK ShareCast News

Broker tips: Kingfisher, Accesso, Hikma 20-May-2025 ShareCast
RBC Capital ups price target on Hikma 20-May-2025 ShareCast
Hikma surges as investors welcome medium-term gu... 15-May-2025 ShareCast

HIK Top Newspaper Links

Hikma boosts injectables business with $300m deal 29-May-2014 Telegraph
MARKET REPORT: Shares jump as Hikma Pharmaceutic... 08-May-2014 Daily Mail
Hikma prepares return to Libya 26-Aug-2011 The Independent

Latest HIK Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

HIK Market Data

Currency UK Pounds
Share Price 1,939.00p
Change Today -25.00p
% Change -1.27 %
52 Week High 2,340.00p
52 Week Low 1,772.00p
Volume 1,793,541
Shares Issued 221.89m
Market Cap £4,302.38m
Beta 0.02
RiskGrade 125

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
85.2% below the market average85.2% below the market average85.2% below the market average85.2% below the market average85.2% below the market average
11.63% above the sector average11.63% above the sector average11.63% above the sector average11.63% above the sector average11.63% above the sector average
Price Trend
34.7% below the market average34.7% below the market average34.7% below the market average34.7% below the market average34.7% below the market average
51.11% above the sector average51.11% above the sector average51.11% above the sector average51.11% above the sector average51.11% above the sector average
Income
19.17% above the market average19.17% above the market average19.17% above the market average19.17% above the market average19.17% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
41.42% above the market average41.42% above the market average41.42% above the market average41.42% above the market average41.42% above the market average
6.67% above the sector average6.67% above the sector average6.67% above the sector average6.67% above the sector average6.67% above the sector average

What The Brokers Say

Strong Buy 6
Buy 3
Neutral 3
Sell 0
Strong Sell 0
Total 12
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Final Interim
Ex-Div 20-Mar-25 15-Aug-24
Paid 01-May-25 20-Sep-24
Amount 48.00¢ 32.00¢

Trades for 01-Aug-2025

Time Volume / Share Price
14:51 0 @ 1,935.00p
11:10 704,109 @ 1,936.00p
11:10 704,109 @ 1,936.00p
16:47 6,199 @ 1,934.03p
16:35 2,045 @ 1,939.00p

HIK Key Personnel

CEO Riad Mishlawi

Top of Page